Garrett Wealth Advisory Group’s AbbVie ABBV Stock Holding History

Garrett Wealth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Sell	5,651 -477	-8%	-$103K	0.22%	42
2026 Q1	$1.33M	Buy	6,128 +2,062	+51%	+$457K	0.24%	38
2025 Q4	$929K	Buy	4,066 +55	+1%	+$12.5K	0.18%	39
2025 Q3	$929K	Buy	4,011 +213	+6%	+$43.4K	0.18%	39
2025 Q2	$705K	Buy	3,798 +1,145	+43%	+$213K	0.15%	48
2025 Q1	$556K	Buy	2,653 +306	+13%	+$59.5K	0.12%	50
2024 Q4	$417K	Buy	2,347 +896	+62%	+$165K	0.09%	64
2024 Q3	$287K	Buy	+1,451	New	+$271K	0.07%	74
2019 Q4	–	Sell	-663	Closed	-$50.2K	–	55
2019 Q3	$50.2K	Buy	+663	New	+$45.5K	0.04%	129

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garrett Wealth Advisory Group's ABBV Position: Q2 2026 in Review

Garrett Wealth Advisory Group reduced its AbbVie (ABBV) stake by 7.8% in Q2 2026, selling an estimated $103K and leaving 5,651 shares worth $1.42M. The position accounts for 0.22% of the portfolio, ranked #42.

Garrett Wealth Advisory Group first reported a position in ABBV in Q3 2019 and has held it in 9 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Garrett Wealth Advisory Group held 5,651 shares of AbbVie worth $1.42M as of Q2 2026.
Garrett Wealth Advisory Group sold 477 AbbVie shares in Q2 2026, an estimated $103K.
AbbVie made up 0.22% of Garrett Wealth Advisory Group's portfolio in Q2 2026, its #42 holding.
Garrett Wealth Advisory Group first reported a position in AbbVie in Q3 2019 and has held it in 9 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Garrett Wealth Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.